Sers, Christine

Combination Therapies with CDK4/6 Inhibitors to Treat KRAS- Mutant Pancreatic Cancer

Goodwin, C. M., Waters, A. M., Klomp, J. E., Javaid, S., Bryant, K. L., Stalnecker, C. A., Drizyte-Miller, K., Papke, B., Yang, R., Amparo, A. M., et al. (2023) · Cancer Research

Pancreatic and Hepatic Oncology ResearchAdvanced Breast Cancer Therapies

Cited by 168

Immunocytochemistry reveals RANKL expression of myeloma cells

Sezer, O., Heider, U., Jakob, C., Zavrski, I., Eucker, J., Possinger, K., Sers, C., & Krenn, V. (2002) · Blood

Multiple Myeloma Research and TreatmentsBone Metabolism and Diseases

Cited by 110

De novo expression of EphA2 in osteosarcoma modulates activation of the mitogenic signalling pathway

Fritsche‐Guenther, R., Noske, A., Ungethüm, U., Kuban, R., Schlag, P. M., Tunn, P., Karle, J., Krenn, V., Dietel, M., & Sers, C. (2010) · Histopathology

Sarcoma Diagnosis and TreatmentAxon Guidance and Neuronal Signaling

Cited by 69

RAS oncogene-mediated deregulation of the transcriptome: From molecular signature to function

Schäfer, R., & Sers, C. (2011) · Advances in Enzyme Regulation

Protein Kinase Regulation and GTPase SignalingGenomics and Chromatin Dynamics

Cited by 12